Article info
PDFInflammatory bowel disease
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial
- Correspondence to:
Dr C S J Probert, University Division of Medicine, Bristol Royal Infirmary, Marlborough St, Bristol BS2 8HW, UK;
c.s.j.probert{at}bristol.ac.uk
Citation
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial
Publication history
- Accepted March 21, 2003
- First published July 1, 2003.
Online issue publication
April 18, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2003 by Gut